Crohn's Disease Treatment Studies

If you are looking for clinical trials for Crohn's disease you have come to the right place! As researchers, our goal is to discover new therapies and information about Inflammatory Bowel Disease (IBD), but most importantly, provide an alternate therapy that helps YOU. We welcome you to the IBD Research Team and encourage you to look at the studies below that you may qualify for. We will update this site periodically, so keep checking this page for new studies. If you have ANY questions or are interested in participating please feel free to call (734) 615-4843 or e-mail higginsSCteam@umich.edu. We hope to hear from you soon!

M20-259 – risankizumab vs ustekinumab

A phase 3, multicenter, randomized, open label, efficacy assessor-blinded study of risankizumab compared to ustekinumab for the treatment of adult subjects with moderate to severe Crohn's disease who have failed anti-TNF therapy

Enrollment status: TBA

Study Coordinator: Andy Brosius

Drug: IV induction / injection under the skin for maintenance